PubMed=16734735; DOI=10.1111/j.1349-7006.2006.00208.x
Szatmari T., Lumniczky K., Desaknai S., Trajcevski S., Hidvegi E.J., Hamada H., Safrany G.
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy.
Cancer Sci. 97:546-553(2006)

PubMed=23248259; DOI=10.4049/jimmunol.1201557
Ohlfest J.R., Andersen B.M., Litterman A.J., Xia J.-Z., Pennell C.A., Swier L.E., Salazar A.M., Olin M.R.
Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model.
J. Immunol. 190:613-620(2013)

PubMed=23686484; DOI=10.4049/jimmunol.1203539
Litterman A.J., Zellmer D.M., Grinnen K.L., Hunt M.A., Dudek A.Z., Salazar A.M., Ohlfest J.R.
Profound impairment of adaptive immune responses by alkylating chemotherapy.
J. Immunol. 190:6259-6268(2013)

PubMed=25894527; DOI=10.1371/journal.pone.0121314
Bausch-Fluck D., Hofmann A., Bock T., Frei A.P., Cerciello F., Jacobs A., Moest H., Omasits U., Gundry R.L., Yoon C., Schiess R., Schmidt A., Mirkowska P., Hartlova A.S., Van Eyk J.E., Bourquin J.-P., Aebersold R., Boheler K.R., Zandstra P.W., Wollscheid B.
A mass spectrometric-derived cell surface protein atlas.
PLoS ONE 10:E0121314-E0121314(2015)

PubMed=30084848; DOI=10.1038/sdata.2018.157
Schuster H., Shao W.-G., Weiss T., Pedrioli P.G.A., Roth P., Weller M., Campbell D.S., Deutsch E.W., Moritz R.L., Planz O., Rammensee H.-G., Aebersold R., Caron E.
A tissue-based draft map of the murine MHC class I immunopeptidome.
Sci. Data 5:180157-180157(2018)

PubMed=30524896; DOI=10.1080/2162402X.2018.1501137
Genoud V., Marinari E., Nikolaev S.I., Castle J.C., Bukur V., Dietrich P.-Y., Okada H., Walker P.R.
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models.
OncoImmunology 7:e1501137.1-e1501137.10(2018)